Thanks for sharing Index, much appreciated!

First 31 Last

Share
Profile

Follow
Edmorgrimm

1,164 Posts.

694

07/03/24

16:28

Post #: 72797857
Share

Originally posted by IndexInvestor: ↑

I asked and Dr Taylor answered.
Here is his answer:
"Thank you so much for your email and welcome to the story of Clarity. Although we value the input from all of our shareholders, Hot Copper is probably not the best source of information, even though we are literally a “hot copper” company! The best source of information is our announcements, and we try to make sure all of our messaging is clear and concise. NorthStar have invested in rhodotrons that manufacture large volumes of Cu-67 for therapy. They do not currently manufacture Cu-64. Cu-64 is made on cyclotrons, and we use a number of sites in the US and Australia to make Cu-64. Cyclotrons only need solid targetry to make Cu-64. Ourselves and our partners also have stockpiles of nickel and there is no shortage of supply. Curium produces Cu-64 commercially and there is significantly less requirement for infrastructure given the optimal half-life of Cu-64 compared to Ga and F. Our competitors are currently worried about our development, and we don’t care. We are running our own race and are too busy with delivering our results and building our company to care for their antics. We are looking forward to sharing an exciting year together with all of our team and shareholders, and I look forward to reporting on more developments shortly. Thanks again for reaching out. Kind regards,
Alan
Dr Alan Taylor

Expand

Thanks for sharing Index, much appreciated!

CU6 Price at posting: $2.81 Sentiment: Buy Disclosure: Held
9 Upvote

0 Great analysis

Reply

Top Stories

BUX

Buxton projects new graphite province discovery at WA Narryer play

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

There are more pages in this discussion • 17 more messages in this thread...

First 31 Last

Add CU6 (ASX) to my watchlist

(20min delay)
Last $8.43		Change -0.300(3.44%)		Mkt cap ! $2.742B

Open	High	Low	Value	Volume
$8.62	$8.68	$8.35	$3.793M	447.7K

Buyers (Bids)

No.	Vol.	Price($)
2	367	$8.43

Sellers (Offers)

Price($)	Vol.	No.
$8.44	1451	5

View Market Depth

No.	Vol.	Price($)
6	1170	8.410
7	3154	8.400
13	8266	8.390
6	8533	8.380
7	3789	8.370

Price($)	Vol.	No.
8.430	779	9
8.440	2298	7
8.450	1826	3
8.460	2728	5
8.470	2970	5

Last trade - 12.50pm 04/10/2024 (20 minute delay)

CU6 (ASX) Chart

Thanks for sharing Index, much appreciated!

Buxton projects new graphite province discovery at WA Narryer play

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Thanks for sharing Index, much appreciated!

Top Stories

Buxton projects new graphite province discovery at WA Narryer play

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News